Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
PEGASPARGASE 750 UNIT/ML INJECTION SOLUTION (CDM RX-92869) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved October 23, 2026 , from http://ppman.hank.ai/transparency/procedure/RX-92869/by-state?code_type=CDM
“PEGASPARGASE 750 UNIT/ML INJECTION SOLUTION (CDM RX-92869) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/RX-92869/by-state?code_type=CDM. Accessed
October 23, 2026 .
“PEGASPARGASE 750 UNIT/ML INJECTION SOLUTION (CDM RX-92869) by State,” HANK Price Transparency ,
accessed October 23, 2026 ,
http://ppman.hank.ai/transparency/procedure/RX-92869/by-state?code_type=CDM.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
CDM · across United States
RX-92869 — Pegaspargase 750 Unit/ml Injection Solution
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$56,954
National median
$49,834 – $73,257
IQR (p25 – p75)
2
hospitals filing
1
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for RX-92869 (CDM), with interquartile range
State Median p25 p75
AL $56,954 $49,834 $73,257